vimarsana.com
Home
Live Updates
Clene Reports New Data from the VISIONARY-MS Phase 2 Study i
Clene Reports New Data from the VISIONARY-MS Phase 2 Study i
Clene Reports New Data from the VISIONARY-MS Phase 2 Study in Multiple Sclerosis Demonstrating CNM-Au8® Treatment Improved Brain Neuronal Structural Integrity
MRI results reinforce the clinical neurological improvements previously reportedMRI results showed improved brain neuronal structural integrity, independent of an immunomodulatory effectMRI results... | February 13, 2023
Related Keywords
Salt Lake City ,
Utah ,
United States ,
Maryland ,
Robert Glanzman ,
Kevin Gardner ,
Michael Barnett ,
Ignacio Guerrero Ros ,
David Schull ,
Benjamin Greenberg ,
Linkedin ,
Twitter ,
Americas Committee For Treatment ,
Clene Nanomedicine Inc ,
Russo Partners ,
Nasdaq ,
Clene Inc ,
Securities Exchange ,
Facebook ,
Research In Multiple Sclerosis ,
Mean Difference ,
Cerebral White Matter ,
Cerebral Normal Appearing White Matter ,
Professor Michael Barnett ,
Chief Medical Officer ,
Americas Committee ,
Multiple Sclerosis ,
Clene Nanomedicine ,
Securities Exchange Act ,
Securities Act ,
Annual Report ,
Quarterly Reports ,
Clene Inc Stock Exchange ,
News ,
Information ,
Press Release ,
Ri ,
Results ,
Reinforce ,
The ,
Linical ,
Neurological ,
Improvements ,
Reviously ,
Eportedmri ,
Howed ,
Mproved ,
Rain ,
Neuronal ,
Structural ,
Independent ,
F ,
N ,
Immunomodulatory ,
Ffectmri Clnn Us1856341029 ,